Table of Contents
Journal of Respiratory Medicine
Volume 2014, Article ID 209583, 7 pages
http://dx.doi.org/10.1155/2014/209583
Research Article

Use of Antiasthmatic Drugs during Pregnancy after the First Trimester and Maternal and Neonatal Outcomes

1Tornblad Institute, Lund University, Biskopsgatan 7, 223 62 Lund, Sweden
2National Board of Health and Welfare, 106 30 Stockholm, Sweden
3Department of Medicine, Centre for Pharmacoepidemiology, Karolinska Institutet, 171 76 Stockholm, Sweden

Received 2 September 2014; Accepted 24 October 2014; Published 13 November 2014

Academic Editor: Christian Kähler

Copyright © 2014 Bengt Källén and Birgitta Norstedt Wikner. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Källén, “The safety of asthma medications during pregnancy,” Expert Opinion on Drug Safety, vol. 6, no. 1, pp. 15–26, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Wang, V. E. Murphy, J. Namazy et al., “The risk of maternal and placental complications in pregnant women with asthma: a systematic review and meta-analysis,” Journal of Maternal-Fetal and Neonatal Medicine, vol. 27, no. 9, pp. 934–942, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. V. E. Murphy, G. Wang, J. A. Namazy et al., “The risk of congenital malformations, perinatal mortality and neonatal hospitalisation among pregnant women with asthma: a systematic review and meta-analysis,” BJOG : An International Journal of Obstetrics and Gynaecology, vol. 120, no. 7, pp. 812–822, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Eltonsy, F.-Z. Kettani, and L. Blais, “Beta2-agonists use during pregnancy and perinatal outcomes: a systematic review,” Respiratory Medicine, vol. 108, no. 1, pp. 9–33, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. B. Källén, “Maternal asthma and use of antiasthmatic drugs in early pregnancy and congenital malformations in the offspring,” Journal of Pulmonary & Respiratory Medicine, vol. 4, p. 166, 2014. View at Publisher · View at Google Scholar
  6. National Board of Health and Welfare. Centre for Epidemiology, “The Swedish Medical Birth Register—a summary of content and quality,” 2003, http://www.socialstyrelsen.se/Publikationer2003/2003-112-3.
  7. B. Wettermark, C. M. Fored, A. Leimanis et al., “The new Swedish prescribed drug register—opportunities for pharmacoepidemiological research and experience from the first six months,” Pharmacoepidemiology and Drug Safety, vol. 16, no. 7, pp. 726–735, 2007. View at Google Scholar
  8. B. Kallen, “A birth weight for gestational age standard based on data in the Swedish Medical Birth Registry, 1985–1989,” European Journal of Epidemiology, vol. 11, no. 5, pp. 601–606, 1995. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Källén and P. Otterblad Olausson, “Use of anti-asthmatic drugs during pregnancy. 1. Maternal characteristics, pregnancy and delivery complications,” European Journal of Clinical Pharmacology, vol. 63, no. 4, pp. 363–373, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Mendola, S. K. Laughon, T. I. Männistö et al., “Obstetric complications among US women with asthma,” American Journal of Obstetrics & Gynecology, vol. 208, no. 2, pp. 127–e8, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Thomsen, D. L. Duffy, K. O. Kyvik, A. Skytthe, and V. Backer, “Relationship between type 1 diabetes and atopic diseases in a twin population,” Allergy, vol. 66, no. 5, pp. 645–647, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. S. W. Wen, K. Demissie, and S. Liu, “Adverse outcomes in pregnancies of asthmatic women: results from a Canadian population,” Annals of Epidemiology, vol. 11, no. 1, pp. 7–12, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Sheiner, M. Mazor, A. Levy, A. Wiznitzer, and A. Bashiri, “Pregnancy outcome of asthmatic patients: a population-based study,” Journal of Maternal-Fetal and Neonatal Medicine, vol. 18, no. 4, pp. 237–240, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Demissie, M. B. Breckenridge, and G. G. Rhoads, “Infant and maternal outcomes in the pregnancies of asthmatic women,” American Journal of Respiratory and Critical Care Medicine, vol. 158, no. 4, pp. 1091–1095, 1998. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Liu, S. W. Wen, K. Demissie, S. Marcoux, and M. S. Kramer, “Maternal asthma and pregnancy outcomes: a retrospective cohort study,” The American Journal of Obstetrics and Gynecology, vol. 184, no. 2, pp. 90–96, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. F. Firoozi, C. Lemière, F. M. Ducharme et al., “Effect of maternal moderate to severe asthma on perinatal outcomes,” Respiratory Medicine, vol. 104, no. 9, pp. 1278–1287, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. V. L. Clifton, W. B. Giles, R. Smith et al., “Alterations of placental vascular function in asthmatic pregnancies,” American Journal of Respiratory and Critical Care Medicine, vol. 164, no. 4, pp. 546–553, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. B. Källén and P. O. Olausson, “Use of anti-asthmatic drugs during pregnancy. 2. Infant characteristics excluding congenital malformations,” European Journal of Clinical Pharmacology, vol. 63, no. 4, pp. 375–381, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. L. Tamási, I. Horváth, A. Bohács, V. Müller, G. Losonczy, and M. Schatz, “Asthma in pregnancy—immunological changes and clinical management,” Respiratory Medicine, vol. 105, no. 2, pp. 159–164, 2011. View at Publisher · View at Google Scholar · View at Scopus